New article on the treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial from the Lancet Infectious Diseases
New aeticle on the International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections from the journal Expert Review of Medical Devices
New article on the State health department validations of central line-associated bloodstream infection events reported via the National Healthcare Safety Network from American Journal of Infection Control
New article on the Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients from the Journal of Vascular Access
New article on The Cost-effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line-Associated Bloodstream Infections from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
New article on Centers for medicare and medicaid services hospital-acquired conditions policy for central line-associated bloodstream infection (CLABSI) and cather-associated urinary tract infection (CAUTI) shows minimal impact on hospital reimbursement from Infection Control & Hospital Epidemiology
Vascular Access - an evidence-based approach 
You must be logged in to post a comment.